File Download
  Links for fulltext
     (May Require Subscription)

Article: Association of Attention-Deficit Hyperactivity Disorder With Myopia Among School Children

TitleAssociation of Attention-Deficit Hyperactivity Disorder With Myopia Among School Children
Authors
Keywordsattention-deficit hyperactivity disorder
COVID-19 pandemic
myopia
Issue Date14-Jul-2025
PublisherC.V. Mosby Co.
Citation
Investigative Ophthalmology & Visual Science, 2025, v. 66, n. 9 How to Cite?
Abstract

Purpose: To determine the relationship of attention-deficit hyperactivity disorder (ADHD) with myopia among school children.

Methods: Children aged six to eight years in Hong Kong were recruited through a stratified, clustered randomized sampling frame and subsequently invited to undergo cycloplegic autorefraction and axial length measurements between 2016 and 2021. ADHD diagnoses were made by qualified physicians according to ICD-10 criteria. ADHD symptoms were assessed using the Strengths and Weaknesses of ADHD-symptoms and Normal-behaviors Questionnaire.

Results: Totally 474 children with ADHD and 9950 control children were included. The age- and sex-adjusted myopia prevalence was lower in ADHD group (21%) versus controls (26%; P = 0.02). Multivariable regression analysis showed less myopia (odds ratio [OR] = 0.75; P = 0.03), higher spherical equivalent refraction (SER) (β = 0.13; P = 0.04), and shorter axial length (AL) (β = −0.07; P = 0.03) in children with ADHD. Specifically, ADHD with oral methylphenidate (MPH) treatment had less myopia (OR = 0.61, P = 0.04), higher SER (β = 0.36; P < 0.001) and shorter AL (β = −0.25; P < 0.001) compared to controls. Each additional month of MPH treatment was associated with a higher SER (β = 0.02; P = 0.01) and shorter AL (β = −0.01; P = 0.01). For each one-point increase in attention-deficit scores, children were found to be less myopic (OR = 0.88, P = 0.01), having higher SER (β = 0.07; P = 0.003) and shorter AL (β = −0.04; P = 0.001). The prevalence of myopia among ADHD increased to 32% during COVID-19 pandemic compared with 23% before COVID-19 pandemic (P = 0.04).

Conclusions: This cross-sectional study found that ADHD is associated with reduced myopia prevalence, more hyperopic SER, and shorter AL. Of note, the observed effect sizes of these associations were small; therefore the interpretation of the clinical meaning needs to be cautious.


Persistent Identifierhttp://hdl.handle.net/10722/358786
ISSN
2023 Impact Factor: 5.0
2023 SCImago Journal Rankings: 1.422

 

DC FieldValueLanguage
dc.contributor.authorChen, Xiu Nian-
dc.contributor.authorZhang, Xiu Juan-
dc.contributor.authorZhang, Yuzhou-
dc.contributor.authorTang, Fangyao-
dc.contributor.authorKam, Ka Wai-
dc.contributor.authorNg, Mandy P.H.-
dc.contributor.authorIp, Patrick-
dc.contributor.authorWong, Ian C.K.-
dc.contributor.authorZhang, Wei-
dc.contributor.authorYoung, Alvin L.-
dc.contributor.authorTham, Clement C.-
dc.contributor.authorPang, Chi Pui-
dc.contributor.authorChen, Li Jia-
dc.contributor.authorYam, Jason C.-
dc.date.accessioned2025-08-13T07:48:01Z-
dc.date.available2025-08-13T07:48:01Z-
dc.date.issued2025-07-14-
dc.identifier.citationInvestigative Ophthalmology & Visual Science, 2025, v. 66, n. 9-
dc.identifier.issn1552-5783-
dc.identifier.urihttp://hdl.handle.net/10722/358786-
dc.description.abstract<p><strong>Purpose</strong>: To determine the relationship of attention-deficit hyperactivity disorder (ADHD) with myopia among school children.</p><p><strong>Methods</strong>: Children aged six to eight years in Hong Kong were recruited through a stratified, clustered randomized sampling frame and subsequently invited to undergo cycloplegic autorefraction and axial length measurements between 2016 and 2021. ADHD diagnoses were made by qualified physicians according to ICD-10 criteria. ADHD symptoms were assessed using the Strengths and Weaknesses of ADHD-symptoms and Normal-behaviors Questionnaire.</p><p><strong>Results</strong>: Totally 474 children with ADHD and 9950 control children were included. The age- and sex-adjusted myopia prevalence was lower in ADHD group (21%) versus controls (26%; <em>P</em> = 0.02). Multivariable regression analysis showed less myopia (odds ratio [OR] = 0.75; <em>P</em> = 0.03), higher spherical equivalent refraction (SER) (<em>β</em> = 0.13; <em>P</em> = 0.04), and shorter axial length (AL) (<em>β</em> = −0.07; <em>P</em> = 0.03) in children with ADHD. Specifically, ADHD with oral methylphenidate (MPH) treatment had less myopia (OR = 0.61, <em>P</em> = 0.04), higher SER (<em>β</em> = 0.36; <em>P</em> < 0.001) and shorter AL (<em>β</em> = −0.25; <em>P</em> < 0.001) compared to controls. Each additional month of MPH treatment was associated with a higher SER (<em>β</em> = 0.02; <em>P</em> = 0.01) and shorter AL (<em>β</em> = −0.01; <em>P</em> = 0.01). For each one-point increase in attention-deficit scores, children were found to be less myopic (OR = 0.88, <em>P</em> = 0.01), having higher SER (<em>β</em> = 0.07; <em>P</em> = 0.003) and shorter AL (<em>β</em> = −0.04; <em>P</em> = 0.001). The prevalence of myopia among ADHD increased to 32% during COVID-19 pandemic compared with 23% before COVID-19 pandemic (<em>P</em> = 0.04).</p><p><strong>Conclusions</strong>: This cross-sectional study found that ADHD is associated with reduced myopia prevalence, more hyperopic SER, and shorter AL. Of note, the observed effect sizes of these associations were small; therefore the interpretation of the clinical meaning needs to be cautious.</p>-
dc.languageeng-
dc.publisherC.V. Mosby Co.-
dc.relation.ispartofInvestigative Ophthalmology & Visual Science-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectattention-deficit hyperactivity disorder-
dc.subjectCOVID-19 pandemic-
dc.subjectmyopia-
dc.titleAssociation of Attention-Deficit Hyperactivity Disorder With Myopia Among School Children-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1167/iovs.66.9.36-
dc.identifier.pmid40657972-
dc.identifier.scopuseid_2-s2.0-105010427924-
dc.identifier.volume66-
dc.identifier.issue9-
dc.identifier.issnl0146-0404-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats